Skip to main content
ConductScienceScienceDex

Ralph R Weichselbaum

NIH Rank #1247
Unclaimed recordClaim profile
  • R01 Holder
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1888723Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Radiology
  • CHEMISTRY

NIH Funding · FY2026

Linked Award Amount
$3.3M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#1,247
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ralph R Weichselbaum. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Ralph R Weichselbaum as a PI. Multi-PI records show the full award amount for context.

  • 4R01CA292860-03R01
    Genetically-engineered Bacteria Overcome Therapy Resistance
    University of Chicago
    $1.8M
    award amount
  • 1R01CA304126-01A1R01
    Spatial and Temporal control of gene therapy in CAR-T cells with ionizing radiation to improve local and distant control of solid tumors
    University of Chicago
    $651.7K
    award amount
  • 5R01CA279802-04R01
    Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
    University of Chicago
    $466.8K
    award amount
  • 5R01CA276307-04R01
    Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
    University of Chicago
    $439.3K
    award amount

Award organization

Organizations that administered FY2026 awards listing Ralph R Weichselbaum as a PI.

FY2026 award administered by University of Chicago (IL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Chicago
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4135
  6. 2024
    Entered Top 25% Nationally
    Ranked #4135
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding
  9. 2026
    Entered Top 10% Nationally
    Ranked #1247

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Ralph R Weichselbaum.

Joseph O Deasy
Weill Cornell Medicine
3
shared awards
Mark Mimee
University of Chicago
3
shared awards
Silvia C. Formenti
Weill Cornell Medicine
3
shared awards
Cristina Montagna
Weill Cornell Medicine
2
shared awards
Encouse Golden
Weill Cornell Medicine
2
shared awards
Laura Santambrogio
Weill Cornell Medicine
2
shared awards
Wenbin Lin
University of Chicago
2
shared awards
John Ng
Weill Cornell Medicine
1
shared award
Kunle Odunsi
University of Chicago
1
shared award

Explore further

Find collaborators for Ralph R Weichselbaum

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →